Antibodies

01 Feb 2008 New Findings Show Enbrel(R) (etanercept) Significantly Reduced Levels of C-Reactive Protein, a Marker of Inflammation, in Patients with Moderate to Severe Plaque Psoriasis
01 Feb 2008 ImmunoGen, Inc. Earns Milestone with IND Filing for BIIB015
31 Jan 2008 Pooled Phase 3 Study of Nplate(TM) (Romiplostim) in Adult Patients with Chronic ITP Published in the Lancet
31 Jan 2008 TargeGen Announces Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients
30 Jan 2008 Viventia Biotech To Explore Strategic Alternatives
29 Jan 2008 Abbott and Eisai Finalize License Agreement in Japan for Additional Indications for Adalimumab, The Only Fully Human Monoclonal anti-TNFalpha Antibody
28 Jan 2008 Avastin receives broad label extension in Europe for the treatment of patients with metastatic colorectal cancer
28 Jan 2008 Abbott and Eisai Announce Changes in the Sales Scheme in Japan for Adalimumab, A Fully Human Monoclonal Anti-TNF-alpha Antibody
28 Jan 2008 Lpath Successfully Humanizes Breakthrough Anti-LPA Antibody, Lpathomab(TM)
28 Jan 2008 Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
25 Jan 2008 MabThera meets study primary endpoint in improving disease symptoms when used as first biologic therapy in patients with rheumatoid arthritis
25 Jan 2008 MabThera increases the time patients with the most common form of adult leukaemia live without their cancer progressing
25 Jan 2008 KRAS Gene Status May Impact Vectibix(TM) (Panitumumab) Efficacy and Patient Reported Outcomes in Advanced Colorectal Cancer Patients
24 Jan 2008 Denosumab Osteoporosis Study Met Primary and All Secondary Bone Mineral Density Endpoints in a Head-to-Head Comparison with Weekly Alendronate (FOSAMAX(R))
22 Jan 2008 CytoFab(TM) phase 2 programme in severe sepsis commenced byAstraZeneca
22 Jan 2008 Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
18 Jan 2008 ThromboGenics and BioInvent Receive Approval to Begin Clinical Trials of TB-403 for the Treatment of Cancer
16 Jan 2008 MorphoSys Discloses GM-CSF as Target of MOR103 Program
16 Jan 2008 New Study Reports Enbrel(R) (Etanercept) Significantly Improved Moderate to Severe Plaque Psoriasis in Children and Adolescents
15 Jan 2008 BioInvent and Genentech Initiate Phase I Clinical Trial for BI-204, a potential treatment for cardiovascular conditions associated with atherosclerosis
15 Jan 2008 Progenics Initiates Phase 2 Clinical Trials for PRO 140, a Novel HIV Antibody Therapy
15 Jan 2008 Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
15 Jan 2008 ZymoGenetics Announces Special Protocol Assessment for Atacicept in General SLE
14 Jan 2008 FDA Approves TYSABRI(R) For The Treatment Of Moderate-To-Severe Crohn's Disease
09 Jan 2008 TRACON Pharmaceuticals Announces Dosing of Initial Three Cancer Patients in a Phase 1 Clinical Trial with TRC105, a Human Chimeric Antibody

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top